Farms.com Home   Ag Industry News

University of Calgary releases new findings on ‘most abundant pig virus’

University of Calgary releases new findings on ‘most abundant pig virus’

Researchers test to determine best age for vaccination

By Jennifer Jackson

Students at the University of Calgary Faculty of Veterinary Medicine (UCVM) found that producers can vaccinate piglets at a younger age than the industry standard for Porcine circovirus type 2 (PCV-2), according to a May 2 release.

Piglets infected with PCV-2 can suffer multiple porcine circovirus-related diseases, such as post-weaning multi-systemic wasting syndrome or porcine dermatitis, according to the UCVM research paper published January 2017.

Some producers feel it is best to vaccinate early but there was little research to back this decision up, says Dr. Markus Czub, professor of virology and emerging infectious disease at UCVM.

“PCV-2 is the most abundant pig virus globally and a major concern for the pig industry,” he said in the May 2 release. “The approach (to vaccinating pigs against the virus) was the-earlier-the-better but there was no data.”

Some common vaccines for PCV2 are registered in Canada for piglets aged starting at three weeks.

Researchers – veterinary students – vaccinated piglets of various ages to determine vaccine efficacy.

After collecting various samples from the pigs, such as saliva and weight, researchers found similar immune responses between piglets vaccinated at less than six days old and at older ages. As a result, researchers found earlier vaccinations could be beneficial in areas such as salivary shedding (spreading the virus through saliva). 


Trending Video

Season 6, Episode 10: Defining Resiliency and the Research Driving Swine Health Forward

Video: Season 6, Episode 10: Defining Resiliency and the Research Driving Swine Health Forward

Genetic research and new technologies continue to influence the future of swine health and production efficiency. In this episode, we explore how research and technology are being used to support stronger, more resilient pigs, while also improving overall production outcomes. In this episode, we are joined by Dr. Jenelle Dunkelberger, geneticist with Topigs Norsvin, to discuss both routine and emerging strategies for improving piglet, pig, and sow livability. She outlines two primary approaches to enhancing resiliency: gene editing and traditional selective breeding. Continuing the resiliency conversation, we also hear from Dr. Lucina Galina, director of technical research projects at the Pig Improvement Company. She shares insights into ongoing gene-editing work focused on PRRS, detailing the pathway to success, regulatory and practical considerations, and the questions that still remain as the technology evolves. Together, these conversations provide a closer look at how research, genetics and innovation are shaping the future of swine health and livability.